MyProstateScore Equivalency With and Without DRE

Status unconfirmed · Not applicable

Conditions studied: Prostate Cancer

In brief

The purpose of the study is to quantify the concordance of MPS results between first-catch urine samples collected post-DRE and those collected without a DRE.

Key facts

Study ID

NCT05700370

Run by

LynxDx

People needed

800

Starts

2022-11-01

Expected to finish

2023-04-01

Last updated by the study team

2023-01-26

Who can join

Age: 45 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Patient is a candidate for prostate biopsy (Bx)
• If Bx naïve and ≤75yo then PSA 3-10 ng/mL
• If Bx naïve and >75yo then PSA 4-10 ng/mL
• If prior negative Bx then PSA may exceed 10 ng/mL
• If DRE very suspicious, then PSA below the thresholds of 3 ng/mL (≤75yo) and 4 ng/mL (>75yo) are acceptable

You may not qualify if…

• Prior diagnosis of prostate cancer

Where it is running

• Arizona State Urological Institute — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.